England is launching a gonorrhea vaccine. Is Canada next?
England will soon begin administering a vaccine to high-risk individuals that may reduce their chances of contracting gonorrhea, but a similar program is not yet in the cards for Canada.
According to studies cited by England's National Health Service, the 4CMenB vaccine, which is presently used in Canada for immunization against meningitis B, has an effectiveness of 32.7 to 42 per cent against gonorrhea.
To combat rising infection rates, the health service said last month it will begin administering the vaccine free of charge in August for those deemed to be at high risk of contracting gonorrhea, including gay and bisexual men who have a history of sexually transmitted infection or multiple sex partners.
But the vaccine has not been authorized for this use in Canada, even as cases of gonorrhea continue to rise across the country.
According to the most recent national statistics, rates of the sexually transmitted infection more than tripled in Canada from 2010 to 2022, going from 11,381 in 2010 to 35,956 in 2022.
Gonorrhea, often referred to as "the clap," is passed on through oral, anal or genital sex.
People who've been infected, especially women, often show no symptoms at all. If left untreated, it can have serious health risks.
In an interview with CBC News on Monday, Calgary physician Caley Shukalek, the chief medical officer for Freddie, an online service that focuses on 2SLGBTQ+ health care, said it's still too soon to know how effective the 4CMenB vaccine will be at preventing new gonorrhea infections.
Early research hasn't been conclusive either, Shukalek said, citing another study conducted by researchers in France that suggested the vaccine may not have any statistical effect on gonorrhea rates.
"I think in the medical community, there's still a bit of skepticism," he said, noting that more research needs to be done before the true impact is known.
The potential upside is promising enough, however, that Shukalek said he has begun prescribing the vaccine to some people who are willing to pay for it out of pocket or through private health insurance.
"Its safety is very well established, so for those at high risk of STIs, I think this is a very worthwhile thing and something that could be considered," he said.
"But because it's kind of what we call off-label, it absolutely is something that needs to be a discussion between a prescriber and a patient to make sure that it's the right decision based on their individual risk."
The vaccine is typically administered in two phases, he said, with the second dose coming at least four weeks after the first.
Chris Aucoin is the executive director of the Health Equity Alliance of Nova Scotia, a group that advocates for those living with HIV and members of the 2SLGBTQ+ community.
He's aware of the latest research on the use of the 4CMenB vaccine to help prevent the spread of gonorrhea, but notes that even if it's approved, it would only be one part of a potential prevention strategy.
Aucoin said the best thing people can do now and in the future to prevent the spread of gonorrhea is to get tested regularly.
"If people are concerned about gonorrhea rates, which are too high … the biggest factor in that for me is the fact that people don't test regularly enough."
He said the recent launch of Nova Scotia's STI Care Now program, which mails out free at-home testing kits for chlamydia, gonorrhea and HIV to anyone interested across the province, is a positive step toward making this easier.
"We now have a tool that's accessible to them in a way that's never been the case in Nova Scotia," he said.
In a statement, the Public Health Agency of Canada said the National Advisory Committee on Immunization is monitoring the latest research on the 4CMenB vaccine.
In a 2023 report, the advisory committee noted that although the vaccine is not currently authorized for this purpose, it may "offer some level of cross-protection against gonococcal infection."
The agency said it expects the committee to further assess this possibility as more evidence becomes available.
Nova Scotia's Department of Health and Wellness echoed this statement, noting that it takes its cues on immunization from the committee
Those looking to pay out of pocket for the vaccine in the private market would be looking at around $200 per dose, the department said.
In 2024, there were 368 new cases of gonorrhea reported in Nova Scotia.
MORE TOP STORIES
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indianapolis Star
9 hours ago
- Indianapolis Star
Indiana's Ryan White opened hearts to AIDS fight. Don't abandon his legacy now.
Ryan White was a spirited, bright kid who loved basketball, Nintendo and dreaming big. In 1984, 13-year-old Ryan contracted HIV through a contaminated blood transfusion used to treat his hemophilia. With widespread misconceptions about HIV/AIDS dominating the headlines, and fear overruling facts, Ryan was barred from attending his school and driven from his hometown of Kokomo. His harrowing story suddenly thrust Ryan onto the national stage, where he transformed the attention into a powerful force for changing perceptions about those living with HIV/AIDS. He had no idea how far his message would reach. Yet he was determined to use it for the greater good. His courage inspired the creation of the Elton John AIDS Foundation, which continues to help people across America, and around the world, stay safe and well. At the time of his diagnosis, doctors gave Ryan only six months to live. On April 8, 1990, six precious years later, we sat together at Ryan's bedside and held his hands as he lost his young, heroic life to AIDS. First lady Barbara Bush attended his funeral, and businessman Donald Trump came to the family home to pay his respects. When Americans needed to take compassionate action, Ryan opened the door and urged everyone to take heart and to help. Four months later, in his name, Congress nearly unanimously enacted the Ryan White CARE Act – providing essential HIV care and treatment to Americans living with the virus. After years of fearmongering and paralysis, the U.S. government had finally committed to join the fight against our common enemy: AIDS. Ryan would be grateful for the progress being made. Today, more than 500,000 Americans living with HIV get lifesaving treatment through the Ryan White CARE Act. In 2019, President Trump proudly launched the End the HIV Epidemic initiative in his State of the Union address − a focused prevention effort to end the HIV epidemic in America by 2030. This evidence-based strategic initiative has achieved remarkable results, reducing new HIV infections by 21% in targeted communities and connecting people newly diagnosed with HIV to vital care and support services. This push to end AIDS is in full swing across America, but the work is not done yet – with young people, particularly in the South, now most severely impacted. We are grateful that the draft budget before Congress continues critically important funding for the Ryan White CARE Act and the End the HIV Epidemic efforts. That is an affirmation of these programs' effectiveness and bipartisan support. However, the proposal also would end federal funding to states for HIV surveillance, testing and education; for community-based organizations that reach those most at risk; and for substance abuse treatment and mental health programs that are crucial for driving down HIV infections. Attempts to cut Medicaid are also alarming, as more than 40% of people living with HIV have their care and treatment covered by Medicaid. Without this essential insurance, scores of people living with HIV won't get the care and medicines they need to keep them healthy. The president has said don't mess with Medicaid. We agree. Programs that provide treatment, fuel prevention and fight stigma should be expanded, not eliminated, as we work toward eradicating the disease that ended Ryan's life. The game-changing opportunity of the moment is to scale up prevention medication that keeps people HIV-free. The recent American-led development of PrEP − a pill or shot that prevents the virus from taking hold − is just the tool we need to end AIDS, but only if we make it accessible to those who need it. The economics are compelling: 14,000 people can receive generic PrEP ($30 annually) for the lifetime cost of treating one person with HIV ($420,285) − keeping Americans healthy, HIV-free and productive. The moment of truth is here. As the administration and Congress consider their investment priorities for next year, we urge them to continue joining forces in the fight against AIDS in the United States and worldwide. Together, their investments over time have created this once-in-a-generation opportunity to end AIDS in America by 2030, as called for by President Trump. Together they can seize that opportunity by banking on prevention. Ryan would expect nothing less.
Indianapolis Star
9 hours ago
- Indianapolis Star
Indiana's Ryan White opened hearts to AIDS fight. Don't abandon his legacy now.
Ryan White was a spirited, bright kid who loved basketball, Nintendo and dreaming big. In 1984, 13-year-old Ryan contracted HIV through a contaminated blood transfusion used to treat his hemophilia. With widespread misconceptions about HIV/AIDS dominating the headlines, and fear overruling facts, Ryan was barred from attending his school and driven from his hometown of Kokomo. His harrowing story suddenly thrust Ryan onto the national stage, where he transformed the attention into a powerful force for changing perceptions about those living with HIV/AIDS. He had no idea how far his message would reach. Yet he was determined to use it for the greater good. His courage inspired the creation of the Elton John AIDS Foundation, which continues to help people across America, and around the world, stay safe and well. At the time of his diagnosis, doctors gave Ryan only six months to live. On April 8, 1990, six precious years later, we sat together at Ryan's bedside and held his hands as he lost his young, heroic life to AIDS. First lady Barbara Bush attended his funeral, and businessman Donald Trump came to the family home to pay his respects. When Americans needed to take compassionate action, Ryan opened the door and urged everyone to take heart and to help. Four months later, in his name, Congress nearly unanimously enacted the Ryan White CARE Act – providing essential HIV care and treatment to Americans living with the virus. After years of fearmongering and paralysis, the U.S. government had finally committed to join the fight against our common enemy: AIDS. Ryan would be grateful for the progress being made. Today, more than 500,000 Americans living with HIV get lifesaving treatment through the Ryan White CARE Act. In 2019, President Trump proudly launched the End the HIV Epidemic initiative in his State of the Union address − a focused prevention effort to end the HIV epidemic in America by 2030. This evidence-based strategic initiative has achieved remarkable results, reducing new HIV infections by 21% in targeted communities and connecting people newly diagnosed with HIV to vital care and support services. This push to end AIDS is in full swing across America, but the work is not done yet – with young people, particularly in the South, now most severely impacted. We are grateful that the draft budget before Congress continues critically important funding for the Ryan White CARE Act and the End the HIV Epidemic efforts. That is an affirmation of these programs' effectiveness and bipartisan support. However, the proposal also would end federal funding to states for HIV surveillance, testing and education; for community-based organizations that reach those most at risk; and for substance abuse treatment and mental health programs that are crucial for driving down HIV infections. Attempts to cut Medicaid are also alarming, as more than 40% of people living with HIV have their care and treatment covered by Medicaid. Without this essential insurance, scores of people living with HIV won't get the care and medicines they need to keep them healthy. The president has said don't mess with Medicaid. We agree. Programs that provide treatment, fuel prevention and fight stigma should be expanded, not eliminated, as we work toward eradicating the disease that ended Ryan's life. The game-changing opportunity of the moment is to scale up prevention medication that keeps people HIV-free. The recent American-led development of PrEP − a pill or shot that prevents the virus from taking hold − is just the tool we need to end AIDS, but only if we make it accessible to those who need it. The economics are compelling: 14,000 people can receive generic PrEP ($30 annually) for the lifetime cost of treating one person with HIV ($420,285) − keeping Americans healthy, HIV-free and productive. The moment of truth is here. As the administration and Congress consider their investment priorities for next year, we urge them to continue joining forces in the fight against AIDS in the United States and worldwide. Together, their investments over time have created this once-in-a-generation opportunity to end AIDS in America by 2030, as called for by President Trump. Together they can seize that opportunity by banking on prevention. Ryan would expect nothing less.
Chicago Tribune
18 hours ago
- Chicago Tribune
As HIV research gutted at federal level, NWI man shares his HIV story
Jeremy Gregson was sitting in his Northwest Indiana home two years ago when he got the call that his blood work from earlier in the day came back positive for HIV. Gregson, 48, said he suffered a stroke in 2023, and when he went to his doctor for follow-up care he told her to test him for everything. Within 30 minutes of testing his blood sample, the doctors learned he was HIV positive, he said. With that knowledge, Gregson said doctors believe his stroke was caused by the HIV virus in his system. Gregson said he approached his diagnosis with medical reasoning, in that he knew what to do next: Get set up with the Aliveness Project of NWI, which is a STD and HIV/AIDS prevention and awareness organization, get medication and get an infectious disease doctor. 'With today's technology and medicines, it's treatable so I said, 'Okay, I'll take a pill,'' Gregson said. 'It was like, 'I'll just take medicine and be fine.'' Human immunodeficiency virus, HIV, damages the immune system, which results in the body being less able to fight infection and disease. Over time, if untreated, HIV can become acquired immunodeficiency syndrome, AIDS, according to the Mayo Clinic. HIV is spread through sexual intercourse, contact with blood or through childbirth. There is no cure for HIV or AIDS, but medicines can control the infection, according to the Mayo Clinic. The most challenging part of his diagnosis, Gregson said, was that his doctor didn't perform the proper testing to determine when he first became HIV positive. Gregson said he has since found a new doctor, and on June 25 he went to take a specialized test to hopefully determine when he first came in contact with the infection. Currently, Gregson takes a pill daily as treatment and his viral load has been so low that he's undetectable. But, Gregson said his viral load has to decrease a little more to qualify for a bimonthly shot, which is his and his doctor's goal. Overall, Gregson said his life has stayed mostly the same since his diagnosis. Recently, the U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr. laid off the entire staff of the federal government's Office of Infectious Disease and HIV/AIDS Policy, as part of a restructuring plan that involved cutting 20,000 HHS positions. Gregson said that move left him feeling confused. 'How does research and testing affect him or anyone else in the government? What is this guy doing?' Gregson said. 'We're so close. They're already testing cures in other countries, and it's working. Why can't we just get this and move forward?' Kennedy has also engaged in HIV and AIDS denialism in one of his books. Protesters interrupted a U.S. Senate hearing on Wednesday where Office of Management and Budget Director Russell Vought was recommending a $400 million cut to global health programs like the President's Emergency Plan for AIDS Relief (PEPFAR), which has helped save 26 million lives and helped nearly 8 million babies to be born HIV-free across the world, according to the George W. Bush Institute. Cutting funding would endanger access to lifesaving antiretroviral medication for more than 20 million people and could put babies at risk of contracting HIV or losing their parents to the disease, the Bush Institute's statement said. The Aliveness Project Program Director Antoinette Cardenas said in a statement that the organization is 'deeply concerned about the federal government's decision to significantly reduce funding and dismantle key HIV/AIDS research.' 'These changes not only jeopardize the progress we've made in prevention, treatment and education but also send a harmful message to communities still disproportionately impacted by HIV — particularly Black, brown, LGBTQ+, and low-income individuals,' Cardenas said. Federal research had played a critical role in improving health outcomes, advancing treatment options and addressing stigma, Cardenas said. 'Scaling back this support risks reversing hard-won gains, especially in areas like Northwest Indiana, where disparities in care and access remain stark,' Cardenas said. The Aliveness Project will remain committed to serving those living with HIV/AIDS through HIV testing, prevention and education, harm reduction, linkage to care and comprehensive care management, Cardenas said. The organization will also expand local partnerships and seek alternative funding sources to sustain and grow its services, Cardenas said. 'We urge federal leaders to reconsider these cuts and reinvest in life-saving research that protects vulnerable populations and upholds public health. Lives depend on it,' Cardenas said. After the layoffs were announced, HIV + Hepatitis Policy Institute executive director Carl Schmid released a statement stating the U.S. cannot take a break from researching and treating infectious diseases as it will result in a rise in infections and medical costs. 'This was not done to increase government efficiency but was a blatant attack on specific communities and populations. With all of these cuts, how are we going to, as Secretary Kennedy repeatedly says, 'Make America Healthy Again'?' Schmid said. UNAIDS released a statement in May ahead of International Day against homophobia, biphobia and transphobia that despite progress in the HIV response LGBTQI+ communities have seen an increase in new HIV infections. Since 2010, new HIV infections have dropped 35% among adults globally, while new HIV infections have increased 11% among gay men and by 3% among trans people, according to the release. 'Threats to the lives and dignity of LGBTI people are escalating worldwide and cuts to foreign and development aid, as well as rollbacks in diversity, equity and inclusion policies, are only making it worse – especially for our communities,' said Julia Ehrt, ILGA World executive director, in the statement. 'Every day, we see projects and organizations to advance safety, well-being and dignity being shut down.' UNAIDS executive director Winnie Byanyima said the organization will continue to support LGBTQ communities throughout the world. 'We must continue supporting and promoting partnerships of LGBTQI+ movements with people living with HIV, women and girls and other key populations. In unity, communities can find the power to disrupt injustice and drive the changes that are required to end AIDs,' Byanyima said. Gregson said he is hopeful that researchers will find ways to continue pushing forward with their work in HIV/AIDS treatment and research. 'The people in that field do it for the passion,' Gregson said.
